Characterising variation in five genetic loci of cytomegalovirus during treatment for congenital infection.

Kadambari, S; Atkinson, C; Luck, S; Macartney, M; Conibear, T; Harrison, I; Booth, C; Sharland, M; Griffiths, P

Journal article

Characterising variation in five genetic loci of cytomegalovirus during treatment for congenital infection.

Abstract:: Cytomegalovirus (CMV) is the most common congenital infection in humans and a leading cause of sensorineural hearing loss. Ganciclovir (6 mg/kg twice daily for 42 days) has been shown to reduce hearing deterioration and is used in clinical practice. Vaccines and passive administration of antibody are being evaluated in randomized controlled trials in allograft candidates, women of childbearing age, and pregnant women with primary CMV infection. To help define genetic variation in each of the targets of these therapeutic interventions, we amplified and sequenced genes UL97 (site utilised for ganciclovir phosphorylation), UL55 (glycoprotein B (gB) vaccine target) and UL128, UL130, and UL131a (specific monoclonal antibody targets). Serial blood, saliva, and urine samples (total 120) obtained from nine infants with symptomatic congenital CMV treated with 42 days' ganciclovir were analyzed. All samples tested were UL97 wild type at baseline and none developed mutations during treatment, showing no selection of resistance. The prevalences of UL55 genotypes were 28% gB1, 22% gB2, 1% gB3, and mixed in 20% samples. No mutations were noted in UL128-131a. Phylogenetic tree analysis showed that sequences with variations were found in multiple body sites of individual patients, so there was no evidence of body site compartmentalization of particular strains of CMV. The significance of these results for changes in diagnostic practices and therapeutic interventions against CMV are discussed. J. Med. Virol. 89:502-507, 2017. © 2016 Wiley Periodicals, Inc.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Kadambari, S., Atkinson, C., Luck, S., Macartney, M., Conibear, T., Harrison, I., Booth, C., Sharland, M., & Griffiths, P. (2016). Characterising variation in five genetic loci of cytomegalovirus during treatment for congenital infection. Journal of Medical Virology, 89(3), 502–507.

MLA Style

Kadambari, S., et al. “Characterising Variation in Five Genetic Loci of Cytomegalovirus during Treatment for Congenital Infection.” Journal of Medical Virology, vol. 89, no. 3, Wiley, 2016, pp. 502–07.

Chicago Style

Kadambari, S, C Atkinson, S Luck, M Macartney, T Conibear, I Harrison, C Booth, M Sharland, and P Griffiths. 2016. “Characterising Variation in Five Genetic Loci of Cytomegalovirus during Treatment for Congenital Infection.” Journal of Medical Virology 89 (3): 502–7.
Share
Print